The manuscript addresses the social, clinical, and institutional dimensions of attention-deficit/hyperactivity disorder (ADHD), with particular emphasis on the problem of medicalization and controversies surrounding pharmacological treatment. It briefly summarizes the discrepancies in epidemiological literature across countries and age groups and critically analyzes selected aspects of DSM-5 criteria (e.g., the undefined threshold for “often”). The paper highlights that the expansion of…
